^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Cizumab (bevacizumab biosimilar)

    Associations
    News
    Trials
    Company:
    Hetero
    Drug class:
    VEGF-A inhibitor
    Related drugs:
    Associations
    News
    Trials